サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1753080

電気けいれん療法の世界市場

Electroconvulsive Therapy

出版日
ページ情報
英文 381 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.72円
電気けいれん療法の世界市場
出版日: 2025年06月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 381 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

電気けいれん療法の世界市場は2030年までに1,890万米ドルに達する見込み

2024年に1,690万米ドルと推定される電気けいれん療法の世界市場は、2030年には1,890万米ドルに達し、分析期間2024-2030年のCAGRは1.9%で成長すると予測されます。本レポートで分析したセグメントの1つである一方的な電気けいれん療法は、CAGR 1.4％を記録し、分析期間終了時には1,280万米ドルに達すると予測されます。二国間電気けいれん療法セグメントの成長率は、分析期間中CAGR 2.7%と推定されます。

米国市場は460万米ドルと推定される一方、中国はCAGR 3.4％で成長すると予測される

米国の電気けいれん療法市場は、2024年に460万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに350万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは3.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.8％と1.6％と予測されています。欧州では、ドイツがCAGR 1.1%で成長すると予測されています。

世界の電気けいれん療法（ECT）市場- 主要動向と促進要因まとめ

電気けいれん療法が精神科治療で再注目されている理由とは？

電気けいれん療法（ECT）は、重度かつ治療抵抗性の精神疾患に対する非常に効果的な治療法として、世界の精神科領域で再注目されています。ECTは、全身麻酔下で制御された電流を脳に流し、医学的に管理された短時間の発作を誘発することで、症状の急速な緩和をもたらします。特に、大うつ病性障害、重度のうつ病や躁病を伴う双極性障害、ある種の統合失調症で、薬物治療に反応しない場合に有効です。かつては物議を醸し、汚名を着せられた治療法であったが、現在では科学的裏付けがあり、エビデンスに基づいた治療法として認知されつつあります。麻酔や筋弛緩剤の使用、最新の電気痙攣治療器による正確な投与など、医療プロトコルの進歩により、電気痙攣治療の安全性と患者の体験は大幅に改善されました。臨床結果は、効果が現れるまでに数週間から数ヵ月かかる薬物療法に比べ、より早く症状が改善することが多いです。世界のストレスの流行、社会的孤立、経済的不安定によって、精神疾患の有病率が上昇していることを考えると、ECTは精神医学のツールキットとしてますます重要になってきており、従来の治療法に反応しない患者に希望を与えています。

ECTの安全性、精度、受容性は、技術革新と臨床革新によってどのように向上しているのか？

現代の電気けいれん療法は、医療技術と神経科学の進歩から大きな恩恵を受けており、より的を絞った患者に優しい治療法へとつながっています。最も重要な改良のひとつは、短パルスおよび超短パルス波形刺激装置の開発であり、これはECTに歴史的に関連してきた認知的副作用、特に記憶障害を軽減するものです。これらの装置により、臨床医は患者の年齢、診断、脳生理学に基づいて刺激パラメーターを調整できるようになり、より個別化された治療が可能になりました。画像誘導による電極配置とセッション中の脳波モニタリングにより、不必要な電流への曝露を最小限に抑えながら、誘発される発作が治療的であることが保証されます。リアルタイムのモニタリング技術の使用により、精度と安全性が向上し、副作用を減らしながら一貫した治療結果を得ることができるようになりました。さらに、メトヘキシタールのような短時間作用型薬剤やサクシニルコリンのような筋弛緩剤の使用を含む最新の麻酔プロトコールは、迅速な回復時間を伴うよりスムーズな処置に貢献しています。現在では、データ管理システムにより、治療経過の追跡、プロトコルの最適化、所見の患者記録への統合が可能となっています。このような技術革新は、ECTを神秘化し、ECTに対する一般の人々や専門家の認識を変えつつあります。その結果、精神科医や擁護団体は、ECTを一連のケアの有効な選択肢として提唱するようになり、スティグマを減らし、重度の精神科症例への早期介入を促進するようになっています。

なぜ地域のヘルスケア政策や文化的認識がECTの利用に影響を与えるのか？

電気けいれん療法の採用と実践は地域によって大きく異なり、ヘルスケアインフラ、規制政策、文化的態度、メンタルヘルスに対する意識レベルに大きく影響されます。米国、カナダ、英国、オーストラリアなどの高所得国では、ECTは入院精神科病棟でも外来精神科診療所でも一般的に行われており、米国精神医学会（APA）や英国王立精神医学会（Royal College of Psychiatrists）などの専門機関による確立されたガイドラインに支えられています。保険適用、医師の訓練、専門施設の存在により、これらの地域ではECTへのアクセスはより安定しています。対照的に、低・中所得国では、限られた精神科医療資源、訓練を受けた人材の不足、時代遅れの設備などの障壁にしばしば直面し、ECTサービスの利用可能性と質が制限されます。さらに、精神疾患にまつわる文化的な偏見や、メディアで描かれるECTへの恐怖が、ECTの受け入れや患者の同意を妨げています。未成年者へのECT使用に法的制限を課したり、司法の承認を必要とする国もあり、これが治療を遅らせたり、妨げたりしています。同意や認知的副作用をめぐる倫理的な議論も、政策や実践を形作っています。しかし、世界のメンタルヘルス・イニシアチブとWHOが支援するプログラムは、緊急精神医療におけるECTの重要性をますます認識し、プロトコルの標準化、臨床家の訓練、十分な治療を受けていない地域でのアクセス拡大に取り組んでいます。このような努力は、多様な集団における重篤な精神疾患の治療ギャップを埋める上で極めて重要です。

世界の電気けいれん療法市場の成長を促進する主な要因は？

世界の電気けいれん療法市場の成長の原動力となっているのは、精神疾患の有病率の上昇、治療抵抗性の患者集団の拡大、安全で効果的な介入としてのECTの制度的認知の高まりです。世界的に数億人が罹患している大うつ病性障害は、ECTが適応となる主な疾患であり、薬物療法に反応しない患者の割合は着実に増加しています。自殺念慮や精神病的特徴を伴う重症うつ病のような、生命を脅かす精神疾患に対するECTの迅速な有効性に対する臨床医や家族の認識の高まりが、公的・私的ヘルスケアシステムにおけるECTの普及を後押ししています。ヘルスケアのインフラ、特に三次精神科医療施設の進歩も一役買っており、より広い範囲での治療が可能になり、患者の転帰も改善されています。さらに、多くの国で高齢化が進んでおり、後期うつ病や認知症に関連した精神症状の発生率が増加しているため、ポリファーマシーと比較して比較的良好なリスク・ベネフィット・プロファイルを持つECTが好まれることが多いです。規制当局の支援と保険償還範囲の拡大は患者にとっての経済的障壁を減らしつつあり、一方ではECTが国家精神保健戦略に盛り込まれたことはその臨床的重要性を強調しています。効果的な精神保健介入に対する世界の需要が高まるにつれ、ECTは重要な治療法として成長し、近代化、エビデンスに基づく擁護、および世界の精神保健の危機に対処する緊急の必要性から恩恵を受ける態勢が整っています。

セグメント

製品タイプ（片側電気けいれん療法,両側電気けいれん療法）;用途（大うつ病性障害,双極性障害,統合失調症,その他の用途）;エンドユーザー（病院＆クリニック,外来手術センター,その他のエンドユーザー）

調査対象企業の例（全48件）

  • Abbott Laboratories（St. Jude Medical）
  • American Medical Distributors Inc.
  • Asia Medical Equipment Co.
  • ECT Supply Solutions Ltd.
  • Ectron Ltd.
  • Global NeuroCare
  • Guangzhou Yeecon Medical Equipment Co., Ltd.
  • High Tech Instruments
  • Hospital Medical Lab Equipments
  • International Electrotherapy Services
  • J&J Medical Systems
  • MECTA Corporation
  • MedEquip Solutions
  • MediSupply Co.
  • MedZell
  • Naugramedical
  • NeuraTech Distributors
  • NeuroMed Partners
  • Recorders & Medicare Systems（RMS India）
  • SigmaStim（Sigma ECT）

AIインテグレーション

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP34992

Global Electroconvulsive Therapy Market to Reach US$18.9 Million by 2030

The global market for Electroconvulsive Therapy estimated at US$16.9 Million in the year 2024, is expected to reach US$18.9 Million by 2030, growing at a CAGR of 1.9% over the analysis period 2024-2030. Unilateral Electroconvulsive Therapy, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$12.8 Million by the end of the analysis period. Growth in the Bilateral Electroconvulsive Therapy segment is estimated at 2.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.6 Million While China is Forecast to Grow at 3.4% CAGR

The Electroconvulsive Therapy market in the U.S. is estimated at US$4.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.5 Million by the year 2030 trailing a CAGR of 3.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.8% and 1.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.1% CAGR.

Global Electroconvulsive Therapy (ECT) Market - Key Trends & Drivers Summarized

Why Is Electroconvulsive Therapy Experiencing Renewed Attention in Psychiatric Treatment?

Electroconvulsive Therapy (ECT) is undergoing a resurgence in the global psychiatric field as a highly effective intervention for severe and treatment-resistant mental health conditions. ECT involves the application of controlled electrical currents to the brain under general anesthesia, inducing a brief, medically supervised seizure that can result in rapid symptom relief. It is particularly effective in cases of major depressive disorder, bipolar disorder with severe depression or mania, and certain forms of schizophrenia, especially when patients do not respond to pharmacological treatments. What once carried a controversial and stigmatized image is now being recognized as a scientifically supported, evidence-based treatment that is often life-saving for individuals at high risk of suicide or catatonia. Advances in medical protocols, including the use of anesthesia, muscle relaxants, and precise dosing with modern ECT machines, have significantly improved the safety and patient experience of the procedure. Clinical outcomes often show quicker symptom improvement compared to medications, which can take weeks or months to show results. Given the rising prevalence of mental health disorders globally-fueled by pandemic stress, social isolation, and economic instability-ECT is becoming increasingly critical in the psychiatric toolkit, offering hope for patients unresponsive to traditional therapies.

How Are Technological and Clinical Innovations Enhancing ECT Safety, Precision, and Acceptance?

Modern electroconvulsive therapy has benefited greatly from advancements in medical technology and neuroscience, leading to more targeted, patient-friendly procedures. One of the most significant improvements is the development of brief-pulse and ultra-brief-pulse waveform stimulators, which reduce the cognitive side effects historically associated with ECT, particularly memory disturbances. These devices allow clinicians to tailor stimulation parameters based on patient age, diagnosis, and brain physiology, enabling more personalized treatments. Image-guided electrode placement and EEG monitoring during sessions ensure that the seizure induced is therapeutic while minimizing exposure to unnecessary current. The use of real-time monitoring technologies has enhanced precision and safety, allowing for consistent therapeutic outcomes with reduced side effects. Furthermore, modern anesthesia protocols, including the use of short-acting agents like methohexital and muscle relaxants such as succinylcholine, contribute to smoother procedures with rapid recovery times. Data management systems now allow institutions to track treatment progress, optimize protocols, and integrate findings into patient records. These innovations are demystifying the procedure and reshaping public and professional perceptions of ECT. As a result, mental health practitioners and advocacy groups are increasingly advocating for ECT as a valid option in the continuum of care, reducing stigma and promoting earlier intervention in severe psychiatric cases.

Why Do Regional Healthcare Policies and Cultural Perceptions Impact the Utilization of ECT?

The adoption and practice of electroconvulsive therapy vary widely across regions, largely influenced by healthcare infrastructure, regulatory policies, cultural attitudes, and mental health awareness levels. In high-income countries such as the United States, Canada, the United Kingdom, and Australia, ECT is commonly offered in both inpatient psychiatric units and outpatient mental health clinics, supported by established guidelines from professional bodies like the American Psychiatric Association (APA) and the Royal College of Psychiatrists. Insurance coverage, physician training, and the presence of specialized facilities make access to ECT more consistent in these regions. In contrast, low- and middle-income countries often face barriers such as limited psychiatric resources, lack of trained personnel, and outdated equipment, which restrict the availability and quality of ECT services. Moreover, cultural stigmas associated with mental illness and fear of ECT as portrayed in media continue to hinder acceptance and patient consent. Some countries impose legal restrictions on its use for minors or require judicial approval, which can delay or prevent treatment. Ethical debates around consent and cognitive side effects also shape policy and practice. However, global mental health initiatives and WHO-backed programs are increasingly recognizing the importance of ECT in emergency psychiatry and are working to standardize protocols, train clinicians, and expand access in underserved regions. These efforts are crucial in bridging the treatment gap for severe mental illnesses across diverse populations.

What Are the Key Drivers Fueling Growth in the Global Electroconvulsive Therapy Market?

The growth in the global electroconvulsive therapy market is being fueled by rising mental health disorder prevalence, expanding treatment-resistant patient populations, and increasing institutional recognition of ECT as a safe and effective intervention. Major depressive disorder, which affects hundreds of millions globally, is the primary condition for which ECT is indicated, and the proportion of patients unresponsive to medications is steadily increasing. The growing awareness among clinicians and families of ECT's rapid effectiveness in life-threatening psychiatric conditions-such as severe depression with suicidal ideation or psychotic features-is driving its uptake in both public and private healthcare systems. Advances in healthcare infrastructure, particularly in tertiary psychiatric care facilities, have also played a role, enabling wider procedural availability and improved patient outcomes. Furthermore, aging populations in many countries are associated with increased incidence of late-life depression and dementia-related psychiatric symptoms, where ECT is often preferred due to its relatively favorable risk-benefit profile compared to polypharmacy. Regulatory support and growing insurance reimbursement coverage are reducing financial barriers for patients, while the inclusion of ECT in national mental health strategies underscores its clinical importance. As global demand for effective mental health interventions intensifies, ECT is poised to grow as a vital therapeutic modality-benefiting from modernization, evidence-based advocacy, and the urgent need to address the global mental health crisis.

SCOPE OF STUDY:

The report analyzes the Electroconvulsive Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Unilateral Electroconvulsive Therapy, Bilateral Electroconvulsive Therapy); Application (Major Depressive Disorder, Bipolar Disorder, Schizophrenia, Other Applications); End-User (Hospitals & Clinics, Ambulatory Surgery Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories (St. Jude Medical)
  • American Medical Distributors Inc.
  • Asia Medical Equipment Co.
  • ECT Supply Solutions Ltd.
  • Ectron Ltd.
  • Global NeuroCare
  • Guangzhou Yeecon Medical Equipment Co., Ltd.
  • High Tech Instruments
  • Hospital Medical Lab Equipments
  • International Electrotherapy Services
  • J&J Medical Systems
  • MECTA Corporation
  • MedEquip Solutions
  • MediSupply Co.
  • MedZell
  • Naugramedical
  • NeuraTech Distributors
  • NeuroMed Partners
  • Recorders & Medicare Systems (RMS India)
  • SigmaStim (Sigma ECT)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Electroconvulsive Therapy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Treatment-Resistant Depression Trends Throw the Spotlight on Electroconvulsive Therapy (ECT)
    • Rising Prevalence of Severe Mood Disorders Propels Demand for ECT in Psychiatric Settings
    • Global Mental Health Crisis Accelerates Investment in Hospital-Based ECT Infrastructure
    • Shift Toward Ambulatory ECT Services Strengthens Accessibility in Outpatient Care Models
    • Aging Population and Geriatric Psychiatry Trends Expand Demand for ECT in Cognitive Disorders
    • Here's the Story: Stigma Reduction and Patient Education Campaigns Improve ECT Acceptance
    • Technological Advancements in Electrode Precision and Dosing Control Enhance Safety and Efficacy
    • Demand for Anesthesia-Integrated ECT Platforms Fuels Market for Turnkey System Providers
    • Growth in Bipolar Disorder and Schizophrenia Management Creates Broader Clinical Use Cases
    • Neurostimulation Market Expansion Encourages Cross-Sector Innovation in ECT Equipment
    • Institutional Reimbursement Support Influences Hospital Investment in ECT Suite Installations
    • AI-Based Patient Selection Tools Improve ECT Personalization and Outcome Prediction
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Electroconvulsive Therapy Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Electroconvulsive Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Electroconvulsive Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Unilateral Electroconvulsive Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Unilateral Electroconvulsive Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Unilateral Electroconvulsive Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Bilateral Electroconvulsive Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Bilateral Electroconvulsive Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Bilateral Electroconvulsive Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Major Depressive Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Major Depressive Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Major Depressive Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Bipolar Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Bipolar Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Bipolar Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Schizophrenia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Schizophrenia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Electroconvulsive Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • JAPAN
    • Electroconvulsive Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • CHINA
    • Electroconvulsive Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • EUROPE
    • Electroconvulsive Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Electroconvulsive Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Electroconvulsive Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • FRANCE
    • Electroconvulsive Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • GERMANY
    • Electroconvulsive Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Electroconvulsive Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Electroconvulsive Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Electroconvulsive Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Electroconvulsive Therapy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Electroconvulsive Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • INDIA
    • Electroconvulsive Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Electroconvulsive Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Electroconvulsive Therapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Electroconvulsive Therapy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Electroconvulsive Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Electroconvulsive Therapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Electroconvulsive Therapy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
  • AFRICA
    • Electroconvulsive Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Electroconvulsive Therapy by Product Type - Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Electroconvulsive Therapy by Product Type - Percentage Breakdown of Value Sales for Unilateral Electroconvulsive Therapy and Bilateral Electroconvulsive Therapy for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Electroconvulsive Therapy by Application - Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Electroconvulsive Therapy by Application - Percentage Breakdown of Value Sales for Major Depressive Disorder, Bipolar Disorder, Schizophrenia and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Electroconvulsive Therapy by End-user - Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Electroconvulsive Therapy by End-user - Percentage Breakdown of Value Sales for Hospitals & Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION